Back
CytomX Therapeutics, Inc. Stock Predictions
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
56
CTMX
CytomX Therapeutics, Inc.
Last Price:
$5.44
Seasonality Move:
12.07%
7 Day Trial
ALL ACCESS PASS
$
7
CytomX Therapeutics, Inc. Stock Forecast
-
Over the next 52 weeks, CytomX Therapeutics, Inc. has on average historically risen by 31.5% based on the past 10 years of stock performance.
-
CytomX Therapeutics, Inc. has risen higher in 3 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 30%
-
Is CytomX Therapeutics, Inc. Stock Undervalued?The current CytomX Therapeutics, Inc. [CTMX] share price is $5.43. The Score for CTMX is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
-
CTMX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
Will CytomX Therapeutics, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, CytomX Therapeutics, Inc. has on average historically risen by 31.5% based on the past 10 years of stock performance.
CytomX Therapeutics, Inc. Stock Rating
Buy
56
CytomX Therapeutics, Inc. (CTMX)
is a Buy
Is CytomX Therapeutics, Inc. overpriced?
-
CytomX Therapeutics, Inc. has risen higher in 3 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 30%
CytomX Therapeutics, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
cytomx.com
52-Week Data
52-Week High:
6.35
52-Week Low:
0.40
Prediction Charts
Market Cap:
920M
Price in USD:
5.43
Volume:
1.9M
Beta:
1.50
Technical Analysis
SMA50:
4.83
SMA100:
4.23
SMA200:
3.21
52-Wk Change:
565.36%
Stock Predictions
-
Is CytomX Therapeutics, Inc. stock public?Yes, CytomX Therapeutics, Inc. is a publicly traded company.
-
What is the CytomX Therapeutics, Inc. stock quote today?The CytomX Therapeutics, Inc. stock price is 5.43 USD today.
-
How to buy CytomX Therapeutics, Inc. stock online?You can buy CytomX Therapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Feb-2 | 5.57 | 6.09 | 6.12 | 5.57 |
| Feb-3 | 6.12 | 6.07 | 6.17 | 5.82 |
| Feb-4 | 6.19 | 5.67 | 6.35 | 5.49 |
| Feb-5 | 5.62 | 5.24 | 5.85 | 5.17 |
| Feb-6 | 5.30 | 5.67 | 5.78 | 5.30 |
| Feb-9 | 5.70 | 5.70 | 6.00 | 5.56 |
| Feb-10 | 5.70 | 5.53 | 5.78 | 5.44 |
| Feb-11 | 5.56 | 5.56 | 5.65 | 5.20 |
| Feb-12 | 5.54 | 5.43 | 5.56 | 5.35 |
| Feb-13 | 5.45 | 5.32 | 5.65 | 5.30 |
| Feb-17 | 5.28 | 5.27 | 5.41 | 5.03 |
| Feb-18 | 5.27 | 5.41 | 5.43 | 5.19 |
| Feb-19 | 5.37 | 5.47 | 5.61 | 5.23 |
| Feb-20 | 5.34 | 5.43 | 5.56 | 5.33 |
CytomX Therapeutics, Inc. Earnings
CytomX Therapeutics, Inc. Earnings Report: Per Share CytomX Therapeutics, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
CytomX Therapeutics, Inc. Forecast Revenue Growth
CytomX Therapeutics, Inc. Stock Analysis: Historical quarterly revenues per share for CytomX Therapeutics, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings decrease this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.34 per share, and a decrease next year of $0.03 per share.
* CytomX Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.